comparemela.com
Home
Live Updates
Fluidx Reports Use of GPX Embolic Device in Challenging Tumo
Fluidx Reports Use of GPX Embolic Device in Challenging Tumo
Fluidx Reports Use of GPX Embolic Device in Challenging Tumor Case
January 20, 2022—Fluidx Medical Technology, a Salt Lake City, Utah–based company that is developing the GPX embolic device, announced that
Related Keywords
Florida ,
United States ,
Auckland ,
New Zealand ,
Salt Lake City ,
Utah ,
Miami Beach ,
Libble Ginster ,
Andrew Holden ,
Martin Krauss ,
Fluidx Medical Technology ,
Interventional Radiology ,
Christchurch Hospital ,
Clinical Interventional Oncology ,
Leipzig Interventional Course ,
Auckland City Hospital ,
Fluidx ,
Px Embolic Device ,
Ludix Medical Technology ,
Ypervascular Tumors ,
Essel Malformations ,
Nternal Bleeds ,
Interventional Oncology ,
Embolic ,
Ncology ,